🇮🇪Ireland
16°C Partly Cloudy · Dublin
Live Updates
--:--:-- IST
Writer Login
Latest
The Pill That Promised a Revolution: Why Eli Lilly's Foundayo Is Launching Slower Than Wall Street Expected Speed Over Scrutiny? The High-Stakes Gamble Behind the NHS's New Fast-Track Drug Pilots A Global Milestone for Wellness: Chanelle McCoy Health Secures Historic Dual SFDA and European Novel Food Regulatory Approvals The Digital and Regulatory Frontier: Top 10 Technical and GMP Trends Shaping Pharma in 2026 Funding the Future: Inside the €75k Women TechEU and £10M Createch Grants for Startups and SMEs FDA Fires Warning Shot at Sanofi's Irish Plant Over Data Cover-Up and Altuviiio Quality Failings Top Universities in Ireland: Discover the Country's Leading Higher Education Institutions The Irish Startup Ecosystem: A Comprehensive Funding and Development Guide for Entrepreneurs The Pill That Promised a Revolution: Why Eli Lilly's Foundayo Is Launching Slower Than Wall Street Expected Speed Over Scrutiny? The High-Stakes Gamble Behind the NHS's New Fast-Track Drug Pilots A Global Milestone for Wellness: Chanelle McCoy Health Secures Historic Dual SFDA and European Novel Food Regulatory Approvals The Digital and Regulatory Frontier: Top 10 Technical and GMP Trends Shaping Pharma in 2026 Funding the Future: Inside the €75k Women TechEU and £10M Createch Grants for Startups and SMEs FDA Fires Warning Shot at Sanofi's Irish Plant Over Data Cover-Up and Altuviiio Quality Failings Top Universities in Ireland: Discover the Country's Leading Higher Education Institutions The Irish Startup Ecosystem: A Comprehensive Funding and Development Guide for Entrepreneurs
Markets · 15 min delay
NBI4,187.6▲ +1.14%
PFE28.42▼ -0.38%
AZN74.18▲ +0.81%
NVO103.55▲ +2.07%
ROG261.40▼ -0.55%
ABBV174.92▲ +0.29%
EUR/USD1.0842▼ -0.12%
ISEQ9,241.3▲ +0.62%
NBI4,187.6▲ +1.14%
PFE28.42▼ -0.38%
AZN74.18▲ +0.81%
NVO103.55▲ +2.07%
ROG261.40▼ -0.55%
ABBV174.92▲ +0.29%
EUR/USD1.0842▼ -0.12%
Updated 04 Jul 2026 · HPRA open data

RISANKIZUMAB - Medicines in Ireland

9 authorised products containing RISANKIZUMAB, from the HPRA register.

A B C D E F G H I J K L M N O P Q R S T U V W X Y Z 0–9
Showing 9 authorised medicines
MedicineActive substanceLicence holderStatus
Skyrizi 150 mg Solution for injection
EU/1/19/1361/003
RISANKIZUMAB AbbVie Deutschland GmbH & Co. KG
Skyrizi 150 mg Solution for injection
EU/1/19/1361/002
RISANKIZUMAB AbbVie Deutschland GmbH & Co. KG
Skyrizi 180 mg Solution for injection
EU/1/19/1361/007
RISANKIZUMAB AbbVie Deutschland GmbH & Co. KG
Skyrizi 180 mg solution for injection in pre-filled syringe
EU/1/19/1361/008-009
RISANKIZUMAB AbbVie Deutschland GmbH & Co. KG
Skyrizi 360 mg Solution for injection
EU/1/19/1361/005
RISANKIZUMAB AbbVie Deutschland GmbH & Co. KG
Skyrizi 55 mg solution for injection in pre-filled syringe
EU/1/19/1361/010
RISANKIZUMAB AbbVie Deutschland GmbH & Co. KG
Skyrizi 600 mg Concentrate for solution for injection
EU/1/19/1361/004
RISANKIZUMAB AbbVie Deutschland GmbH & Co. KG
Skyrizi 75 mg Solution for injection
EU/1/19/1361/001
RISANKIZUMAB AbbVie Deutschland GmbH & Co. KG
Skyrizi 90 mg Solution for injection
EU/1/19/1361/006
RISANKIZUMAB AbbVie Deutschland GmbH & Co. KG
Cite this database

Priya Life Science (2026). Irish Medicines Database. Available at: https://priyalifescience.com/medicines (Accessed: 7 July 2026).

Data: Health Products Regulatory Authority (HPRA) open dataset (“Authorised or Transfer Pending Products”), licensed CC BY 4.0, refreshed daily. Regulatory information only — not medical advice.